Inovio Pharmaceuticals Inc. (NYSEMKT:INO), a well-known manufacturer of synthetic vaccines needs money to run its various projects and it has announced a way to attain that objective. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) stock opened at $3.20 in last session, and closed at $3.55, while the day range of Inovio Pharmaceuticals Inc. (NYSEMKT:INO) stock is $3.00 – $3.55. The stock showed a positive weekly performance of -4.57%.
Dyax Corp. logo Dyax Corp. (NASDAQ:DYAX) CMO Burt A. Adelman sold 55,000 shares of the stock in a transaction dated Monday, March 3rd. Dyax Corp. (NASDAQ:DYAX) stock opened at $9.37 in last session, and closed at $10.31 by gaining 6.62%. The 52 week range of $2.26 – $10.99. Company’s market capitalization is $1.13B.
XOMA Corporation (NASDAQ:XOMA) announced that the U.S. Food and Drug Administration (FDA) awarded orphan drug designation to gevokizumab for the treatment of pyoderma gangrenosum (PG). XOMA Corp (NASDAQ:XOMA) stock increased 6.58% and finished the last session at $8.91. The EPS of the stock remained -0.80. Company’s market capitalization is $775.46M.
BioCryst Pharmaceuticals, Inc. logo Oppenheimer began coverage on shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) in a research note issued to investors on Friday, TheFlyOnTheWall. The firm issued a market perform rating on the stock. BCRX has been the subject of a number of other recent research reports. Analysts at Piper Jaffray initiated coverage on shares of BioCryst Pharmaceuticals in a research note on Thursday, February 20th. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stock opened the session at $11.86, and closed the session at $12.41. The 52 week range of the BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stock remained $1.12 – 13.33 and the day range was $11.53 – 12.47.